Kaplan-Meyer survival of myeloma patients according to del(17p). (A) Overall survival. (B) Progression-free survival. The blue curve corresponds to patients with del(17p) alone, the red curve to patients with biallelic inactivation of TP53, and the black curve to patients without del(17p) (control cohort).